Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEUROMYELITIS OPTICA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
graph TD
NEUROMYELITIS_OPTICA[NEUROMYELITIS OPTICA]
NEUROMYELITIS_OPTICA -->|causes| Cognitive_Decline[Cognitive Decline]
AQP4[AQP4] -.biomarker for.-> NEUROMYELITIS_OPTICA
Chi3L1[Chi3L1] -.biomarker for.-> NEUROMYELITIS_OPTICA
CHI3L1[CHI3L1] -.biomarker for.-> NEUROMYELITIS_OPTICA
AQP4_AB[AQP4-AB] -->|causes| NEUROMYELITIS_OPTICA
AQP4_ab[AQP4-ab] -->|causes| NEUROMYELITIS_OPTICA
Neuroinflammation[Neuroinflammation] -->|causes| NEUROMYELITIS_OPTICA
immune_tolerance[immune tolerance] -.protects against.-> NEUROMYELITIS_OPTICA
B_Cells[B Cells] -->|involved_in| NEUROMYELITIS_OPTICA
CR2_Crry[CR2-Crry] -->|treats| NEUROMYELITIS_OPTICA| Target | Relation | Type | Str |
|---|---|---|---|
| Cognitive Decline | causes | phenotype | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AQP4 | biomarker_for | protein | 0.95 |
| CHI3L1 | biomarker_for | protein | 0.90 |
| AQP4-AB | causes | protein | 0.90 |
| Neuroinflammation | causes | process | 0.90 |
| AQP4 | associated_with | protein | 0.90 |
| Chi3L1 | biomarker_for | biomarker | 0.90 |
| AQP4-ab | causes | protein | 0.90 |
| AQP4 | markers | gene | 0.90 |
| immune tolerance | protects_against | process | 0.87 |
| CR2-Crry | treats | compound | 0.85 |
| B Cells | protects_against | cell_type | 0.85 |
| B Cells | involved_in | cell_type | 0.85 |
| Microglia | contributes_to | cell_type | 0.85 |
| Satralizumab | treats | drug | 0.80 |
| Complement Cascade | causes | pathway | 0.80 |
| Inebilizumab | treats | drug | 0.80 |
| complement C3 | mediates | protein | 0.80 |
| Eculizumab | treats | drug | 0.80 |
| AQP4 | involved_in | protein | 0.80 |
| Tolerance | protects_against | process | 0.80 |
| Rituximab | treats | drug | 0.70 |
| AQP4 | implicated_in | protein | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity